Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Aimmune Therapeutics.
Release Date: September 28, 2018
Expiration Date: September 28, 2019
Media: Internet - based
Of all food allergies, peanut allergies cause the most severe cases of anaphylaxis and represent the leading cause of death from food-induced anaphylaxis. With a prevalence of approximately 2% of the US population, there is no clear-cut understanding of why peanut allergies have continued to increase. Furthermore, not only are patients and caregivers burdened with strict avoidance at all times and constant wariness of accidental exposure but with additional costs of outpatient and emergency visits or hospitalizations for severe reactions. However, a paradigm shift in peanut allergy management is evolving. In this Clinical Practice Connections™, expert faculty will address myths and misconceptions about food allergies, outline appropriate diagnosis and provide expert panel addendum guideline recommendations for early introduction of peanut protein to infants at various risk levels. Children and adults with peanut allergies may soon benefit from ongoing clinical trials of desensitization treatments as faculty describe three emerging immunotherapies and considerations for incorporation into practice.
This activity is supported by an educational grant from by Aimmune Therapeutics.
This CME activity is primarily intended for allergists, immunologists, primary care physicians, pediatricians, and clinicians who treat patients with peanut allergy.
At the conclusion of this activity, you should be better prepared to:
David R. Stukus, MD
Associate Professor of Pediatrics
Division of Allergy and Immunology
Nationwide Children’s Hospital and The Ohio State University College of Medicine
Disclosure: No relevant financial information to disclose
The staff of Physicians' Education Resource®, LLC, (PER®) have no relevant financial relationships with commercial interests to disclose.
As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.
Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.
Hematology Briefings™: Advancing Care and Improving Outcomes for Patients With Pyruvate Kinase Deficiency
Oct 31, 2018
Oct 31, 2018
Oct 31, 2018